|
 |
FDA Approval Activities for this Drug…
EVOXAC (cevimeline HCl) Capsules, 30 mg, SnowBrand NDA 20-989 1/11/00 1/19/00 1/19/00 3/12/02 EVOXAC Indication: for the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|